NSEAppointment10 Jul 2026 · 10 Jul 2026, 10:53 pm
Appointment
Hindustan Construction Company Limited · HCC
✦ AI SummaryMgmt Change
Hindustan Construction Company Limited has appointed Mr. Nakul Pasricha as a Non-Executive Independent Director, effective July 10, 2026, for a term of 5 years, subject to shareholder approval.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Hindustan Construction Company Limited has informed the Exchange regarding Appointment of Mr. Nakul Pasricha as Non- Executive Independent Director of the company w.e.f. July 10, 2026.
Attachments (1)
📄pdf
Download →
HCC_10072026225315_Exchange.pdf
View document text
HCC/SEC/APT/2026 July 10, 2026
BSE Limited National Stock Exchange of India limited
The Corporate Relationship Dept, Exchange Plaza,
Phiroze Jeejeebhoy Towers, Sandra Kurla Complex,
Dalal Street, Sandra (East),
Mumbai-400 001 Mumbai-400 051
Scrip Codes: 500185, 974246, 974247, Symbol- HCC
974 249 & 97 4250
Dear Sir I Madam,
Sub :Intimation under Regulations 30 and 51 of the SEBI (listing Obligations and Disclosure
Requirements) Regulations, 2015
Pursuant to the provisions of Regulations 30 and 51 read with Schedule Ill of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, kindly take note that based on the
recommendations of the Nomination and Remuneration Committee of the Company, the Board of
Directors, vide its Circular Resolution passed today i.e. July 10, 2026, has appointed Mr. Nakul
Pasricha (DIN: 03176843), as an Additional (Non-Executive Independent) Director of the Company,
not liable to retire by rotation, for a term of 5 (five) consecutive years with effect from July 10, 2026.
The abovementioned appointment is subject to obtaining approval of the Members of the Company
in the ensuing General Meeting or within three months from the date of his appointment, whichever
is earlier as per Regulation 17(1 C) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
Kindly take note that Mr. Nakul Pasricha is not debarred from holding the office of Director by virtue
of any SEBI order or order of any other such Authority.
The disclosure pursuant to SEBI Master Circular No. H0/49/14/14(7)2025-CFDPOD2/I/3762/2026
dated January 30, 2026 is enclosed as Annexure A.
Kindly take the above on record.
Yours sincerely,
For Hindustan Construction Company Ltd.
Nitesh Kumar Jha
Company Secretary
Encl.: As above.
Hindustan Construction Co ltd
Hincon House, lal Bahadur Shastri Marg,
Vikhroli (West), Mumbai 400 083, India
Tel : + 91 22 2577 5959 Fax : + 91 22 2577 7568 www .hccindia.com
Annexure A
The disclosure pursuant to SEBI Master Circular No. H0/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026
Sr. Particulars Details
1. Reason for change viz. Appointment
appointment, re-appointment,
resignation, removal, death or
otherwise
2. Date of appointment/re- Appointed Mr. Nakul Pasricha (DIN: 03176843), as an
appointment/cessation (as Additional (Non-Executive Independent) Director of the
applicable) & term of Company, not liable to retire by rotation, for a term of 5
appointment/re-appointment (five) consecutive years with effect from July 10, 2026,
subject to obtaining approval of the Members of the
Company in the ensuing General Meeting or within three
months from the date of his appointment, whichever is
earlier as per Regulation 17( 1 C) of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations,
2015.
3. Brief Profile Nakul Pasricha is a versatile business leader with over 27
years' experience spanning multiple geographies,
industries and company sizes. He is the MD & CEO for
PharmaSecure, a leading provider of technology enabled
anti-counterfeiting solutions to the pharmaceutical and
other industries in India, Africa and beyond.
At PharmaSecure, Mr. Pasricha first led the development
of patented technology solutions to protect medicines and
supply chains against counterfeiting and then invested in
and took on leadership of the company, growing it to serve
over 1 00 companies in the pharmaceutical and other
sectors, with more than 10 billion packs protected to date
in India and Africa. He was granted a patent as a co
inventor of the technology engine that drives
PharmaSecure's authentication solution.
In addition to his primary role, Mr. Pasricha has served on
the governing body of the Authentication Solution
Providers' Association (ASPA), a not-for-profit body
devoted to research, awareness and advocacy of
solutions to prevent counterfeiting. He has been elected
President of ASPA for two terms and is currently Vice
President. In this role, Mr. Pasricha has been a strong
public advocate of stringent measures to curb the loss of
life and revenue from counterfeiting across sectors. He
has led the publication of the seminal report on
www .hccindia.com
counterfeiting, "A State of Counterfeiting in India",
frequently used as a reference to better understand the
issue from a consumer perspective. He has also overseen
the launch and growth of the conference series,
"Traceability and Authentication Forum", bringing together
stakeholders from industry, government and the solution
provider ecosystem.
Mr. Pasricha also serves on the National Intellectual
Property Rights Committee of the Confederation for Indian
Industry (CII) where he contributes to conversations
around IPR and counterfeiting.
Mr. Pasricha is Co-Promoter and Director of Flexing It,
India and Asia's largest platform for independent
consultants and professional freelance talent. Founded in
2014, Flexinglt® is a category leader in on-demand talent
solutions, connecting 2000+ organisations with 10 0,000+
vetted consultants and experts across strategy,
operations, technology, and transformation. Recognised
as a high-growth startup in APAC by the Financial Times
and a strategic partner to large enterprise clients, Flexing
It® enables rapid access to the right expertise through
flexible, outcome-driven engagement models.
Previously, Mr. Pasricha served in technology leadership
roles across a variety of organizations, starting his career
at Citibank (U.S.A.), overseeing global technology
implementations. He was part of the team at the forefront
of IT outsourcing to India ahead of Y2K.
After moving to India in 2005, Mr. Pasricha served as the
Chief Information Officer of General Electric's consumer
finance division, overseeing a team of 120 people
implementing and supporting financial systems for the
loans business, and managing projects for SBI Cards,
which was at that time a JV with GE.
Mr. Pasricha has participated as a speaker or moderator
in conferences organized by Cll, Assocham, PHDCII and
other organizations, and contributed to counterfeiting
related stories in leading publications including: Business
World, Business Standard, Economic Times, The Hindu,
Express Pharma, Financial Times, Deutsche Welle and
Channel News Asia.
Mr. Pasricha has a B.A. in Mathematics and Computer
Science from Gettysburg College, and an M.S. in
Computer Science from the University of Maryland at
College Park. He is an Indian citizen and resident.
www .hccindia.com
He serves as Board Director for PharmaSecure Inc.
(USA), PharmaSecure PAS India Pvt. Ltd., Flexing It
Services Pte Ltd. (Singapore) and Flexing It Services Pvt.
Ltd.
4. Disclosure of relationships Mr. Nakul Pasricha is not related to any Director of the
between Directors Company.
www.hccindia.com